
{
    "credit": [
        {
            "email": "gpatrinos@upatras.gr",
            "name": "George P Patrinos",
            "typeEntity": "Person",
            "typeRoles": [
                "Primary contact"
            ],
            "url": "http://www.genomicmedicinealliance.org/working-groups/pharmacogenomics/80-genomic-medicine-alliance/137-drugevar-database"
        }
    ],
    "function": [
        {
            "operation": [
                {
                    "term": "Data handling",
                    "uri": "http://edamontology.org/operation_2409"
                },
                {
                    "term": "Visualisation",
                    "uri": "http://edamontology.org/operation_0337"
                },
                {
                    "term": "Query and retrieval",
                    "uri": "http://edamontology.org/operation_0224"
                }
            ]
        }
    ],
    "labels": {
        "cost": "Free of charge",
        "maturity": "Emerging",
        "operatingSystem": [
            "Linux",
            "Windows",
            "Mac"
        ],
        "toolType": [
            "Database portal"
        ],
        "topic": [
            {
                "term": "Pharmacology",
                "uri": "http://edamontology.org/topic_0202"
            },
            {
                "term": "Pharmacogenomics",
                "uri": "http://edamontology.org/topic_0208"
            }
        ]
    },
    "publication": [
        {
            "abstract": "Â© 2014 S. Karger AG, Basel. Background/Aims: Pharmacogenomics aims to rationalize drug use by minimizing drug toxicity and/or by increasing drug efficacy. A large number of genomic markers have been correlated with variable drug responses and severity of adverse drug reactions. Although a number of these drugs bear pharmacogenomic information in their labels - approved by regulatory agencies - and comprehensive drug/gene lists exist online, information related to the respective pharmacogenomic biomarkers is currently missing from such lists. Methods: We extracted information from the published literature and online resources and developed DruGeVar (http://drugevar.genomicmedicinealliance.org), an online resource triangulating drugs with genes and pharmacogenomic biomarkers in an effort to build a comprehensive database that could serve clinical pharmacogenomics. Results and Conclusions: A user-friendly data querying and visualization interface allows users to formulate simple and complex queries. Such a database would be readily applicable as a stand-alone resource or a plug-in module for other databases.",
            "authors": [
                "Dalabira E.",
                "Viennas E.",
                "Daki E.",
                "Komianou A.",
                "Bartsakoulia M.",
                "Poulas K.",
                "Katsila T.",
                "Tzimas G.",
                "Patrinos G.P."
            ],
            "cit_count": 12,
            "journal": "Public Health Genomics",
            "pmid": "25228099",
            "title": "DruGeVar: An online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics",
            "year": "2014-12-25"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:drugevar",
        "biotoolsID": "drugevar",
        "description": "A database triangulating between drugs, genes and pharmacogenomics biomarkers in regulatory agencies-approved drugs",
        "homepage": "http://www.genomicmedicinealliance.org/working-groups/pharmacogenomics/80-genomic-medicine-alliance/137-drugevar-database",
        "name": "DruGeVar"
    }
}